Clinical evaluation of 3% Ara-A ointment (MJD-1741) in patients with herpes simplex.
スポンサーリンク
概要
- 論文の詳細を見る
The clinical effects of MJD-1741 (3% Ara-A ointment) were evaluated in 54 cases With herpes simplex by open study.<BR>MJD-1741 led to a rapid improvement and influenced the disease duration. The efficacy rate was 73.5%. In recurrent herpes simplex, eruptions were improved more rapidly than episodes.<BR>As local side effects, contact dermatitis was observed in 2 out of 54 cases (3.7%), but closed patch tests were all negative.<BR>It was concluded that MJD-1741 was a useful and reliable ointment for the treatment of herpes simplex.
- 日本皮膚科学会大阪地方会の論文
日本皮膚科学会大阪地方会 | 論文
- ツベルクリン皮内反応部に出現する浸潤細胞の電顕的観察
- セフメタゾ-ル・ナトリウムによりSystemic eczematous contact-type dermatitis medicamentosaと急性腎不全を生じた1例 (単純化学物質による皮膚障害)
- 歯科金属アレルギ-による全身の扁平苔癬の1例 (接触皮膚炎とパッチテスト-4-)
- Oakmoss Allergyを示すPigmented Cosmetic Dermatitisの1例 (単純化学物質による皮膚障害)
- 漢方薬中のCinnamic系化合物による薬疹の1例 (単純化学物質による皮膚障害) -- (職業性および薬剤性皮膚炎と薬疹)